New Covid-19 treatments for highest risk Covid patients (non-hospitalised patients)

New treatments for patients at highest risk of severe disease from Covid 19 infection are available for non-hospitalised patients from Thursday 16 December.

The treatments include Neutralising monoclonal antibodies (nMABs) given by injection, or antiviral tablets which are swallowed. These treatments are being given to patients at a dedicated clinic, known as the Covid Medical Delivery Unit. GP practices cannot prescribe these treatments and they are only licenced for patients with the highest risk with COVID-19.

People who can benefit from these treatments will receive a letter or email telling them in advance, they may be eligible for these treatments if they test PCR positive for Covid-19. They also may be contacted by their specialist consultant.

Information about the treatments can be found on the NHS website:
www.nhs.uk/conditions/coronavirus/treatments.

We are facing high demand at the moment so please only contact the surgery about new treatments for Covid-19, if you have a medical condition that means you are very high risk and have tested positive for Covid-19.

Covid antiviral trials.

If you have tested positive for Covid-19 and would like to take part in trials using antiviral treatments the surgery recommends you to self-refer to the PANORAMIC study where the study organisers will assess your eligibility.